1 |
Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017[J]. CA Cancer J Clin,2017,67(1):7-30.
|
2 |
Gluth A, Werner J, Hartwig W. Surgical resection strategies for locally advanced pancreatic cancer[J]. Langenbecks Arch Surg, 2015, 400(7):757-765.
|
3 |
中国癌症研究基金会介入医学委员会.晚期胰腺癌介入治疗临床操作指南(试行)[J].临床肝胆病杂志,2017,33(2):221-232.
|
4 |
Spadi R, Brusa F, Ponzetti A, et al. Current therapeutic strategies for advanced pancreatic cancer: A review for clinicians[J]. World J ClinOncol,2016,7(1):27-43.
|
5 |
Lu DS, Raman SS, Vodopich DJ, et al. Effect of vesselsize on creation of hepatic radiofrequency lesions in pigs: assessment of the "heat sink" effect[J]. AJR Am J Roentgenol, 2002, 178(1):47-51.
|
6 |
Gehl J. Electroporation: theory and methods, perspectives for drug delivery,gene therapy and research[J]. Acta Physiol Scand, 2003, 177(4):437-47.
|
7 |
Chang DC, Reese TS. Changes in membrane structure induced by electroporationas revealed by rapid-freezing electron microscopy[J]. Biophys J, 1990,58(1):1-12.
|
8 |
Joshi RP, Schoenbach KH. Bioelectric effects of intense ultrashort pulses[J]. Crit Rev Biomed Eng,2010,38(3):255-304.
|
9 |
Lee EW, Wong D, Prikhodko SV, et al. Electronmicroscopic demonstration and evaluation of irreversible electroporation-induced nanopores on hepatocyte membranes[J]. J Vasc Interv Radiol, 2012, 23(1):107-113.
|
10 |
Zhang Z, Li W, Procissi D, et al. Rapid dramaticalterations to the tumor microstructure in pancreatic cancer following irreversible electroporation ablation[J]. Nanomedicine (Lond), 2014, 9(8):1181-1192.
|
11 |
Petrishia A, Sasikala M. Molecular simulation of cell membrane deformation by picosecond intense electric pulse[J]. J Membr Biol, 2015,248(6):1015-1020.
|
12 |
Paiella S, Salvia R, Ramera M, et al. Local ablative strategies for ductal pancreatic cancer (radiofrequency ablation, irreversible electroporation): A review[J]. Gastroenterol Res Pract, 2016, 2016:4508376.
|
13 |
Vogel JA, van Veldhuisen E, Agnass P, et al. Time-dependent impact of irreversible electroporation on pancreas, liver, blood vessels and nerves: a systematic review of experimental studies[J]. PLoS One, 2016,11(11):e0166987.
|
14 |
Bower M, Sherwood L, Li Y, et al. Irreversible electroporation of thepancreas: definitive local therapy without systemic effects[J]. J Surg Oncol, 2011,104(1):22-28.
|
15 |
José A, Sobrevals L, Ivorra A, et al. Irreversible electroporation shows efficacy against pancreatic carcinoma without systemic toxicity in mouse models[J]. Cancer Lett, 2012, 317(1):16-23.
|
16 |
Fritz S, Sommer CM, Vollherbst D, et al. Irreversible electroporation of the pancreas isfeasible and safe in a porcine survival model[J]. Pancreas, 2015 ,44(5):791-798.
|
17 |
Martin RC 2nd, Durham AN, Besselink MG, et al. Irreversible electroporation in locally advanced pancreatic cancer: A call for standardization of energy delivery[J]. J Surg Oncol, 2016,114(7):865-871.
|
18 |
Martin RC. Irreversible electroporation of locally advanced pancreatic headadenocarcinoma[J]. J Gastrointest Surg,2013,17(10):1850-1856.
|
19 |
Scheffer HJ, Vroomen LG, de Jong MC, et al. Ablation of locally advanced pancreatic cancer with percutaneous irreversible electroporation: results of the Phase I/II PANFIRE study[J]. Radiology, 2017, 282(2):585-597.
|
20 |
Månsson C, Nilsson A, Karlson BM. Severe complications with irreversible electroporation of the pancreas in the presence of a metallic stent: a warning of a procedure that never should be performed[J]. Acta Radiol Short Rep, 2014,3(11):2047981614556409.
|
21 |
Månsson C, Brahmstaedt R, Nilsson A, et al. Percutaneous irreversible electroporation for treatment of locally advanced pancreatic cancer following chemotherapy or radiochemotherapy[J]. Eur J SurgOncol, 2016,42(9):1401-1406.
|
22 |
Yan L, Chen YL, Su M, et al. A single-institution experience with open irreversible electroporation for locally advanced pancreatic carcinoma[J]. Chin Med J (Engl), 2016 ,129(24):2920-2925.
|
23 |
Martin RC, Schwartz E, Adams J, et al. Intra–operative anesthesia management in patients undergoing surgical irreversible electroporation of the pancreas, liver, kidney, and retroperitoneal tumors[J].Anesth Pain Med, 2015, 5(3):e22786.
|
24 |
Nielsen K, Scheffer HJ, Vieveen JM, et al. Anaesthetic management during open andpercutaneous irreversible electroporation[J]. Br J Anaesth, 2014, 113(6):985-992.
|
25 |
Martin RC 2nd, Kwon D, Chalikonda S, et al. Treatment of 200 locally advanced (stage III) pancreaticadenocarcinoma patients with irreversible electroporation: safety and efficacy[J].Ann Surg, 2015, 262(3):486-494.
|
26 |
Narayanan G, Hosein PJ, Beulaygue IC, et al. Percutaneous image-guided irreversible electroporation for the treatment of unresectable, locally advanced pancreatic adenocarcinoma[J]. J VascInterv Radiol, 2017, 28(3):342-348.
|
27 |
Kluger MD, Epelboym I, Schrope BA, et al. Single-Institution experience with irreversible electroporation for T4 pancreatic cancer: first 50 patients[J]. Ann Surg Oncol, 2016, 23(5):1736-1743.
|
28 |
Belfiore G, Belfiore MP, Reginelli A, et al. Concurrent chemotherapy alone versus irreversible electroporation followed by chemotherapy on survival in patients with locally advanced pancreatic cancer[J]. Med Oncol, 2017, 34(3):38.
|
29 |
Martin RC 2nd, McFarland K, Ellis S, et al. Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma[J]. J Am Coll Surg, 2012, 215(3):361-369.
|
30 |
Martin RC 2nd, McFarland K, Ellis S, et al. Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival[J]. Ann Surg Oncol, 2013, 20(Suppl 3):S443-449.
|
31 |
Lambert L, Horejs J, Krska Z, et al. Treatment of locally advanced pancreatic cancer by percutaneous andintraoperative irreversible electroporation: general hospital cancer center experience[J]. Neoplasma, 2016,63(2):269-273.
|
32 |
Månsson C, Bergenfeldt M, Brahmstaedt R, et al. Safety and preliminary efficacy of ultrasound-guided percutaneous irreversible electroporation for treatment of localized pancreatic cancer[J]. Anticancer Res,2014,34(1):289-293.
|
33 |
Belfiore MP, Ronza FM, Romano F, et al. Percutaneous CT-guided irreversible electroporation followed by chemotherapy as a novel neoadjuvant protocol in locally advancedpancreatic cancer: Our preliminary experience[J]. Int J Surg, 2015, 21(Suppl 1):S34-39.
|
34 |
Bond L, Schulz B, VanMeter T, et al. Intra-operative navigation of a 3-dimensional needle localization system for precision of irreversible electroporation needles in locally advanced pancreatic cancer[J]. Eur J Surg Oncol, 2017 ,43(2):337-343.
|
35 |
Akinwande O, Ahmad SS, Van Meter T, et al. CT findings of patients treated with irreversible electroporation for locally advanced pancreatic cancer[J]. J Oncol, 2015,2015:680319.
|
36 |
Vroomen LGPH, Scheffer HJ, Melenhorst MCAM, et al. MR and CT imaging characteristicsand ablation zone volumetry of locally advanced pancreatic cancer treated with irreversible electroporation[J]. Eur Radiol, 2017 ,27(6):2521-2531.
|
37 |
Ekici Y, Tezcaner T, Aydın HO, et al. Arterial complication ofirreversible electroporation procedure for locally advanced pancreatic cancer[J].World J Gastrointest Oncol, 2016,8(10):751-756.
|
38 |
Philips P, Li Y, Li S, et al. Efficacy of irreversible electroporation in human pancreatic adenocarcinoma: advanced murine model[J]. Mol Ther Methods Clin Dev, 2015 ,2:15001.
|
39 |
Wimmer T, Srimathveeravalli G, Gutta N, et al. Comparison of simulation-based treatment planning with imaging and pathology outcomes for percutaneous CT-guided irreversible electroporation of the porcine pancreas: a pilot study[J]. J Vasc Interv Radiol, 2013,24(11):1709-1718.
|
40 |
Martin RC 2nd. Irreversible electroporation of locally advanced pancreatic neck/body adenocarcinoma[J]. J Gastrointest Oncol, 2015 ,6(3):329-335.
|
41 |
Scheffer HJ, Melenhorst MC, Vogel JA, et al. Percutaneous irreversible electroporation of locally advanced pancreatic carcinoma using the dorsal approach: a case report[J]. Cardiovasc Intervent Radiol, 2015,38(3):760-765.
|
42 |
Dunki-Jacobs EM, Philips P, Martin RC 2nd. Evaluation of resistance as ameasure of successful tumor ablation during irreversible electroporation of thepancreas[J]. J Am Coll Surg, 2014, 218(2):179-187.
|
43 |
Bhutiani N, Agle S, Li Y, et al. Irreversible electroporation enhances delivery of gemcitabine to pancreatic adenocarcinoma[J]. J Surg Oncol, 2016,114(2):181-186.
|
44 |
Li J, Liu F, Gupta S, et al. Interventional nanotheranostics of pancreatic ductal adenocarcinoma[J]. Theranostics, 2016 ,6(9):1393-1402.
|
45 |
Li X, Xu K, Li W, et al. Immunologic response to tumorablation with irreversible electroporation[J]. PLoS One, 2012,7(11):e48749.
|
46 |
Goswami I, Coutermarsh-Ott S, Morrison RG, et al. Irreversible electroporation inhibits pro-cancer inflammatory signaling in triple negative breast cancer cells[J]. Bioelectrochemistry, 2017,113:42-50.
|
47 |
Lin M, Liang S, Wang X, et al. Short-termclinical efficacy of percutaneous irreversible electroporation combined with allogeneic natural killer cell for treating metastatic pancreatic cancer[J]. Immunol Lett, 2017,186:20-27.
|
48 |
Martin RC 2nd, Agle S, Schlegel M, et al. Efficacy of preoperative immunonutrition in locally advanced pancreatic cancer undergoing irreversible electroporation (IRE) [J]. Eur J Surg Oncol, 2017,43(4):772-779.
|